EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

CD44-Receptors-Mediated Multiprong Targeting Strategy Against Breast Cancer and Tumor-Associated Macrophages: Design, Optimization, Characterization, and Cytologic Evaluation

Zahid Hussain iD, Lama Abdulrahim Abdul Moti, Jayalakshmi Jagal, Hnin Ei Thu, Shahzeb Khan, Mohsin Kazi iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s480553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Zahid Hussain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates. Hauptthemen laut MEDLINE: Breast Neoplasms, Hyaluronan Receptors, Tumor-Associated Macrophages. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHyaluronan ReceptorsTumor-Associated MacrophagesHumansFemalePaclitaxelNanoparticlesMCF-7 CellsTamoxifenChitosanHyaluronic AcidAnimalsMiceApoptosisCell Line, TumorAntineoplastic AgentsDrug CarriersDrug Delivery SystemsDrug Liberation

Stichwörter der Autor:innen

CD44-receptorsanticancer efficacybreast cancercell uptakehyaluronic acidpaclitaxelpolymeric nanoparticlestamoxifen

Substanzen

PaclitaxelHyaluronan ReceptorsTamoxifenChitosanHyaluronic AcidCD44 protein, humanAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Department of Pharmacology, Faculty of Dentistry, Universiti Teknologi MARA, Sungai Buloh Campus, Sungai Buloh, Selangor, Malaysia.
  • Center for Pharmaceutical Engineering Science, Faculty of Life Sciences, School of Pharmacy and Medical Sciences, University of Bradford, West Yorkshire Bradford, BD7 1DP, UK.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, 11451 Saudi Arabia.

ORCID-Profile: Zahid Hussain, Mohsin Kazi

Zitieren

APA

Hussain, Z., Abdulrahim Abdul Moti, L., Jagal, J., Thu, H. E., Khan, S., & Kazi, M. (2025). CD44-Receptors-Mediated Multiprong Targeting Strategy Against Breast Cancer and Tumor-Associated Macrophages: Design, Optimization, Characterization, and Cytologic Evaluation. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s480553

Vancouver

Hussain Z, Abdulrahim Abdul Moti L, Jagal J, Thu HE, Khan S, Kazi M. CD44-Receptors-Mediated Multiprong Targeting Strategy Against Breast Cancer and Tumor-Associated Macrophages: Design, Optimization, Characterization, and Cytologic Evaluation. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s480553

BibTeX
@article{Hussain2025,
  author = {Hussain, Zahid and Abdulrahim Abdul Moti, Lama and Jagal, Jayalakshmi and Thu, Hnin Ei and Khan, Shahzeb and Kazi, Mohsin},
  title = {CD44-Receptors-Mediated Multiprong Targeting Strategy Against Breast Cancer and Tumor-Associated Macrophages: Design, Optimization, Characterization, and Cytologic Evaluation},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s480553}
}
Kostenlos starten →